SPON2 and neoplasm: SPON2 is associated with cellular adhesion,[16] whereas THBS1 is involved in angiogenic and tumorigenic activity such that it is frequently mutated in the context of cancer progression.[17] Heterozygous THSD7B variants can result in decreases in cellular adhesion together with enhanced tumor cell invasivity and metastasis.